Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.
Status:
Unknown status
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
To determine whether addition of Carvedilol CR to diabetic patients with hypertension who are
receiving the ACEi,Lisinopril,will provide added benefits to blood vessels when compared to
treatment with Lisinopril alone.It is believed that carvedilol provides added benefits by
suppressing free radicals(charged substances that cause damage to the body ) and
inflammation.